← Martin Shkreli StreamsTrade on Robinhood →Trade on Hyperliquid →Trade on Hyperliquid →Trade on Robinhood →Trade on Hyperliquid →Trade on Robinhood →Trade on Robinhood →Trade on Robinhood →Trade on Robinhood →
“This drug don't work. … There's no chance in hell this drug works.”
@Martin Shkreli Streams
SLS is a zero, the drug does not work and the multi-billion valuation collapses
SLSSHORT@ $10.33
$9.85+4.63%
since call Jun 25
peak +11.3%
“I question the Intel rally quite a bit and think it could be a good pair trade, uh, as a short against some other … more interesting companies.”
@Martin Shkreli Streams
Intel rally is unjustified, expensive turnaround with weak growth, ripe for a short pair trade
INTCSHORT@ $133.20
$88.24+33.75%
since call Jun 25
peak +38.4%
“Apple will fall … Alphabet number 3 at $4.2 billion, spitting distance from taking over, um, Apple at number 2.”
@Martin Shkreli Streams
Apple will fall, lagging the AI leaders and ceding ground to Alphabet
AAPLSHORT@ $278.01
$304.11-9.39%
since call Jun 25
“Sharon AI told investors NVIDIA was a strategic shareholder and then withdrew the statement. … That's the type of shit that they put me in jail.”
@Martin Shkreli Streams
Sharon AI is a fraud, securities filings lie about NVIDIA backing, short it
SHAZSHORT@ $80.36
$48.85+39.21%
since call Jun 25
peak +50.4%
“bullish on OpenAI. I think the numbers were quite good and I think their revenue has gone up quite a lot.”
@Martin Shkreli Streams
OpenAI revenue surging, bullish on the AI leader as private champion
MSFTLONG@ $352.08
$470.96+33.77%
since call Jun 25
peak +33.8%
“nivenobart is an every 3 or every 6 month dosing”
@Martin Shkreli Streams
BioCryst worth ~$28 vs $10 on Phase 3 nivenobart upside, a long-acting HAE drug
BCRXLONG@ $9.73
$8.82-9.44%
since call Jun 25
“I'm bullish on AbbVie. … Biotech is a game that unfolds over years, not over days”
@Martin Shkreli Streams
AbbVie bullish, a multi-year biotech story to be patient with
ABBVLONG@ $241.29
$253.80+5.19%
since call Jun 25
peak +9.8%
“Biotech takes time. Same thing as AbbVax.”
@Martin Shkreli Streams
Long Avivax through a buyout, an all-in biotech bet
AVXLLONG@ $2.48
$2.79+12.84%
since call Jun 25
peak +12.8%
“It looks very scammy … their only customer doesn't have the money to make anything work.”
@Martin Shkreli Streams
Short Chazz, a scammy data center name reliant on one cash-poor customer
APLDSHORT@ $41.49
$27.80+33.00%
since call Jun 25
peak +43.3%
TIMESTAMPS
5:49
10:00
26:07
38:31
44:15
78:28
78:28
107:27
115:56